# Subclinical Hyperthyroidism

> Subclinical hyperthyroidism for NEET-PG Medicine covers suppressed TSH with normal thyroid hormones, its causes, cardiac and bone risks and when to treat.

- Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/subclinical-hyperthyroidism
- Exam / course: NEET-PG · Subject: Medicine
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-14
- Last updated: 2026-10-14
- Reference basis: Williams Textbook of Endocrinology; Davidson's Principles and Practice of Medicine
- How to cite: "Subclinical Hyperthyroidism", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/subclinical-hyperthyroidism

## Direct answer

Subclinical hyperthyroidism is a suppressed serum TSH with normal free T4 and T3 in a patient without the clinical features of thyrotoxicosis. It is linked to atrial fibrillation and osteoporosis, with risk rising as TSH falls, particularly below about 0.1 mU/L, and treatment decisions depend on age, cardiac disease, bone health and the underlying cause.

## What you must remember

- **Biochemical definition:** suppressed TSH with normal free T4 and T3, confirmed on repeat testing.
- **Common causes:** early Graves disease, toxic nodules, multinodular goitre, thyroiditis and excess levothyroxine.
- **Non-thyroidal causes:** glucocorticoids, dopamine, octreotide and acute illness can lower TSH and must be excluded.
- **Atrial fibrillation:** the main cardiac risk, particularly in older patients, and the risk rises as TSH falls.
- **Bone:** increased risk of osteoporosis and fracture, most relevant in postmenopausal women.
- **Treatment threshold:** TSH below about 0.1 mU/L is the level at which treatment is most commonly considered, especially with cardiac or bone risk.
- **Pregnancy:** raised hCG in early pregnancy lowers TSH, so trimester-specific ranges are needed before labelling the patient.

## A cause-based approach to subclinical hyperthyroidism

The diagnosis must be confirmed and the cause identified before treatment is considered. Repeat testing and a focused review of drugs and thyroid imaging guide the decision.

| Cause | Typical clue | Next step |
|---|---|---|
| Early Graves disease | Goitre, eye signs, raised TSH receptor antibodies | Antibody testing and antithyroid drug decision |
| Toxic nodule | Palpable nodule, focal uptake on scan | Scintigraphy and nodule evaluation |
| Multinodular goitre | Multiple nodules, usually older patients | Scintigraphy, then treatment decision |
| Thyroiditis | Painful or painless gland, low uptake | Observe and treat symptoms |
| Levothyroxine excess | Dose above need, drug history | Reduce the dose and repeat tests |
| Non-thyroidal low TSH | Glucocorticoids, dopamine, acute illness | Stop the drug and repeat after recovery |

Exogenous levothyroxine and drug effects are the most reversible causes, so they should be corrected before any treatment decision is made. A repeat TSH and free T4 after several weeks confirm whether the suppression persists. Only then is the cardiac and bone risk weighed against the patient's age and comorbidity.

## Where the exam tries to catch you

Examiners test whether the diagnosis is confirmed and whether the cause is treated before the thyroid.

- **Trap:** Treating a single suppressed TSH without repeating it. — **Correct:** Repeat testing confirms the biochemistry, because transient illness and drugs can suppress TSH temporarily.
- **Trap:** Ignoring levothyroxine over-replacement as a cause. — **Correct:** Exogenous thyroxine is a common reversible cause, and reducing the dose may restore a normal TSH.
- **Trap:** Treating every subclinical case regardless of TSH level. — **Correct:** Treatment is considered most strongly when TSH is below about 0.1 mU/L, especially with cardiac or bone risk, and mild suppression is often observed.

## Frequently asked questions

### What TSH level is usually considered high risk in subclinical hyperthyroidism?

A TSH below about 0.1 mU/L is generally considered the higher-risk range in subclinical hyperthyroidism, with the risk of atrial fibrillation and bone loss increasing as TSH falls. Thresholds vary by guideline, so age and comorbidity also guide treatment.

### Why is subclinical hyperthyroidism linked to atrial fibrillation?

Subclinical hyperthyroidism is linked to atrial fibrillation because even mild excess thyroid hormone affects atrial electrophysiology and heart rate. Older patients and those with pre-existing heart disease carry the greatest risk, which is why cardiac status is checked.

### Which drugs can suppress TSH and mimic subclinical hyperthyroidism?

Glucocorticoids, dopamine and octreotide can suppress TSH and mimic subclinical hyperthyroidism. Acute illness can do the same, so these causes must be excluded and the test repeated before treatment is decided.

### Does subclinical hyperthyroidism in pregnancy need treatment?

In early pregnancy, raised hCG can lower TSH and mimic subclinical hyperthyroidism. Trimester-specific ranges and free T4 guide any decision, and antithyroid drugs are generally avoided unless free T4 is raised.